Dishevelled binding antagonist of beta catenin 1

DACT1
Identifiers
AliasesDACT1, DAPPER, DAPPER1, DPR1, FRODO, HDPR1, THYEX3, dishevelled binding antagonist of beta catenin 1, TBS2
External IDsOMIM: 607861; MGI: 1891740; HomoloGene: 9613; GeneCards: DACT1; OMA:DACT1 - orthologs
Orthologs
SpeciesHumanMouse
Entrez

51339

59036

Ensembl

ENSG00000165617

ENSMUSG00000044548

UniProt

Q9NYF0

Q8R4A3

RefSeq (mRNA)

NM_001079520
NM_016651

NM_001190466
NM_021532

RefSeq (protein)

NP_001072988
NP_057735

NP_001177395
NP_067507

Location (UCSC)Chr 14: 58.63 – 58.65 MbChr 12: 71.36 – 71.37 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Dishevelled binding antagonist of beta catenin 1 (Dact1, previously known as Dapper, Dpr1, Frodo) is a protein that in humans is encoded by the DACT1 gene. Dact1 was originally described in 2002 as a negative regulator of Wnt signaling by binding and destabilizing Dishevelled. More recent investigation into the molecular function of Dact1 has identified its principal role in the cell as a scaffold to generate membrane-less biomolecular condensates through liquid-liquid phase separation. Mutations in the phase-separating regions of Dact1 lead to Townes-Brock Syndrome 2 while its overexpression is associated with bone metastasis.